Relevance of the Concept of Oncogene Addiction to Hormonal Carcinogenesis and Molecular Targeting in Cancer Prevention and Therapy
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many tumors lacking p16INK4a or overexpressing D-type cyclins have shown exquisite sensitivity to CDK4/6 inhibitors, whereas many normal cells are relatively resistant, implying that cancer cells become “addicted” to RB pathway mutations (132).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [132]
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Addiction to Oncogenes--the Achilles Heal of Cancer
Weinstein, I. B. (2002) · Science · doi:10.1126/science.1073096 · Cited by 1,728
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
HUGGINS, C. (1941) · Archives of Surgery · doi:10.1001/archsurg.1941.01210140043004 · Cited by 1,499
The molecular portraits of breast tumors are conserved across microarray platforms
Hu, Z., Fan, C., Oh, D. S., Marron, J., He, X., Qaqish, B. F., Livasy, C., Carey, L. A., Reynolds, E., Dressler, L., et al. (2006) · BMC Genomics · doi:10.1186/1471-2164-7-96 · Cited by 1,491
The changing global patterns of female breast cancer incidence and mortality
Bray, F., McCarron, P., & Parkin, D. M. (2004) · Breast Cancer Research · doi:10.1186/bcr932 · Cited by 1,007
Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G., & Corti, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1145 · Cited by 815
The transcriptional repressor Snail promotes mammary tumor recurrence
Moody, S. E., Perez, D., Pan, T.-C., Sarkisian, C. J., Portocarrero, C. P., Sterner, C. J., Notorfrancesco, K. L., Cardiff, R. D., & Chodosh, L. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.009 · Cited by 750
Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy
Weinstein, I. B., & Joe, A. K. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0558 · Cited by 705
Sirtuins as potential targets for metabolic syndrome
Guarente, L. (2006) · Nature · doi:10.1038/nature05486 · Cited by 468
Mechanisms Underlying the Development of Androgen-Independent Prostate Cancer
Pienta, K. J., & Bradley, D. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0067 · Cited by 430
D'Cruz, C. M., Gunther, E. J., Boxer, R. B., Hartman, J. L., Sintasath, L., Moody, S. E., Cox, J. D., Ha, S. I., Belka, G. K., Golant, A., et al. (2001) · Nature Medicine · doi:10.1038/84691 · Cited by 418
Protective effect of green tea against prostate cancer: A case‐control study in southeast China
Jian, L., Xie, L. P., Lee, A. H., & Binns, C. W. (2004) · International Journal of Cancer · doi:10.1002/ijc.11550 · Cited by 369
Shimizu, M., Deguchi, A., Lim, J. T. E., Moriwaki, H., Kopelovich, L., & Weinstein, I. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2014 · Cited by 347
Moody, S. E., Sarkisian, C. J., Hahn, K. T., Gunther, E. J., Pickup, S., Dugan, K. D., Innocent, N., Cardiff, R. D., Schnall, M. D., & Chodosh, L. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00212-x · Cited by 345
Changing demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
Adhami, V. M., Siddiqui, I. A., Ahmad, N., Gupta, S., & Mukhtar, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2840 · Cited by 296
Suganuma, M., Okabe, S., Kai, Y., Sueoka, N., Sueoka, E., & Fujiki, H. (1999) · PubMed · Cited by 236
Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies
Sun, C.-L., Yuan, J.-M., Koh, W.-P., & Yu, M. C. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi276 · Cited by 233
Kavanagh, K. T., Hafer, L. J., Kim, D. W., Mann, K. K., Sherr, D. H., Rogers, A. E., & Sonenshein, G. E. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1164 · Cited by 223
Khafif, A. (1998) · Carcinogenesis · doi:10.1093/carcin/19.3.419 · Cited by 221
An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors
Dong, B., Kim, S., Hong, S., Das Gupta, J., Malathi, K., Klein, E. A., Ganem, D., DeRisi, J. L., Chow, S. A., & Silverman, R. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610291104 · Cited by 219
Structure–activity relationships for inhibition of human 5α-reductases by polyphenols
Hiipakka, R. A., Zhang, H.-Z., Dai, W., Dai, Q., & Liao, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00848-1 · Cited by 216
Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis
Gunther, E. J., Moody, S. E., Belka, G. K., Hahn, K. T., Innocent, N., Dugan, K. D., Cardiff, R. D., & Chodosh, L. A. (2003) · Genes & Development · doi:10.1101/gad.1051603 · Cited by 214
Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines
Lim, J. T. E., Piazza, G. A., Han, E. K.-H., Delohery, T. M., Han, L., Finn, T. S., Buttyan, R., Yamamoto, H., Sperl, G. J., Brendel, K., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00200-2 · Cited by 209
Pianetti, S., Guo, S., Kavanagh, K. T., & Sonenshein, G. E. (2002) · PubMed · Cited by 207
Tea intake, COMT genotype, and breast cancer in Asian-American women.
Wu, A. H., Tseng, C.-C., Berg, D. V. D., & Yu, M. C. (2003) · PubMed · Cited by 190
Masuda, M., Suzui, M., Lim, J. T. E., & Weinstein, I. B. (2003) · PubMed · Cited by 165
Caporali, A. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh235 · Cited by 139
EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells
Shimizu, M., Deguchi, A., Hara, Y., Moriwaki, H., & Weinstein, I. B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.182 · Cited by 135
Goluboff, E. T., Shabsigh, A., Saidi, J. A., Weinstein, I. B., Mitra, N., Heitjan, D. F., Piazza, G. A., Pamukcu, R., Buttyan, R. E., & Olsson, C. A. (1999) · Urology · doi:10.1016/s0090-4295(98)00513-5 · Cited by 127
Deguchi, A., Thompson, W. J., & Weinstein, I. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3740 · Cited by 125
Rising prostate cancer rates in South Korea
Park, S. K., Sakoda, L. C., Kang, D., Chokkalingam, A. P., Lee, E., Shin, H., Ahn, Y., Shin, M., Lee, C.-W., Lee, D., et al. (2006) · The Prostate · doi:10.1002/pros.20419 · Cited by 116
Blakely, C., Stoddard, A., Belka, G., Dugan, K. D., Notarfrancesco, K. L., Moody, S., D'Cruz, C., & Chodosh, L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4235 · Cited by 109
Lim, J. T. E., Mansukhani, M., & Weinstein, I. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501203102 · Cited by 102
Colomer, R., Lupu, R., Bacus, S. S., & Gelmann, E. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.405 · Cited by 99
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
Shimizu, M., Deguchi, A., Joe, A. K., McKoy, J., Moriwaki, H., & Weinstein, I. B. (2005) · PubMed · Cited by 97
Lathrop, A. E. C., & Loeb, L. (1916) · PubMed · Cited by 95
FURTHER INVESTIGATIONS ON THE ORIGIN OF TUMORS IN MICE
Lathrop, A. E. C., & Loeb, L. (1915) · The Journal of Experimental Medicine · doi:10.1084/jem.22.5.646 · Cited by 81
Goluboff, E. T., Prager, D., Rukstalis, D. B., Giantonio, B. J., MADORSKY, M., Barken, I., Weinstein, I. B., Partin, A. W., & Olsson, C. A. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65856-9 · Cited by 79
Han, E. K.-H., Arber, N., Yamamoto, H., Lim, J. T. E., Delohery, T. M., Pamukcu, R., Piazza, G. A., Xing, W. Q., & Weinstein, I. B. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005924730450 · Cited by 72
Prostate cancer : principles and practice
Kantoff, P. W., Carroll, P. R., D'Amico, A. V., Ross, R. K., Isaacs, J. T., & Scher, H. I. (2002) · Cited by 71
Ovarian Secretion and Tumor Incidence
Murray, W. S. (1927) · Science · doi:10.1126/science.66.1720.600 · Cited by 57
Lim, J. T. E., Piazza, G. A., Pamukcu, R., Thompson, W. J., & Weinstein, I. B. (2003) · PubMed · Cited by 32
Lim, J. T. E., Joe, A. K., Suzui, M., Shimizu, M., Masuda, M., & Weinstein, I. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2051 · Cited by 15
Cited by
Targeting CDK4 and CDK6: From Discovery to Therapy
Sherr, C. J., Beach, D., & Shapiro, G. I. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0894 · Cited by 936
Targeting the DNA Damage Response in Cancer
Ljungman, M. (2009) · Chemical Reviews · doi:10.1021/cr900047g · Cited by 163
Cell Cycle–Targeted Cancer Therapies
Sherr, C. J., & Bártek, J. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-040716-075628 · Cited by 130
“However, tumor cells driven by deregulated mutant oncoproteins may become addicted to the resulting high signaling thresholds and, thus, exhibit a heightened dependency on recruited downstream signal transducers (Luo et al. 2009, Pagliarini et al. 2015, Weinstein 2008).”
BackgroundEPMA position paper in cancer: current overview and future perspectives
Grech, G., Zhan, X., Yoo, B. C., Bubnov, R. V., Hagan, S., Danesi, R., Vittadini, G., & Desiderio, D. M. (2015) · The EPMA Journal · doi:10.1186/s13167-015-0030-6 · Cited by 109
“This hypersensitivity is the basis of targeted therapies [306].”
BackgroundEstrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Fuqua, S. A. W., Gu, G., & Rechoum, Y. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2847-4 · Cited by 85
“In certain genes, activating mutations might confer enhanced sensitivity, perhaps through ‘‘addiction’’ to a specific growth or survival pathway [18].”
Background
Metadata
- Authors
- Weinstein, B.
- Affiliations
- Columbia University (US)
- Corresponding author
- Weinstein, Bernard
- Venue
- Advances in experimental medicine and biology
- Publisher
- Springer New York
- Published
- 2008
- Volume
- 617
- Pages
- 3-13
- ISSN
- 0065-2598 (ISSN-L)
- OpenAlex
- W14187310
- Cited by
- 17
- References
- 49
- Citations by year
- 2020: 2 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 1.61
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in experimental medicine and biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- oncogene addiction, hormonal carcinogenesis, breast cancer, prostate cancer, cancer prevention, molecular targeting, cancer therapy, exogenous risk factors, Westernization
- MeSH terms
- Animals, Antineoplastic Agents, Breast Neoplasms, Catechin, Female, Humans, Male, Neoplasms, Hormone-Dependent, Oncogenes, Prostatic Neoplasms, Sulindac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.